Valeant Pharmaceuticals Intern...
NYSE: VRX
$23.40
Closing price July 13, 2018
Rite Aid, Valeant, Frontier Communications, and DryShips all posted new 52-week lows on Monday.
Published:
Last Updated:
Valeant Pharmaceuticals announced that it intends to refinance some of its debt. One key analyst thinks that this might be a sign to abandon ship.
Published:
Last Updated:
Valeant Pharmaceuticals shares hit a multiyear low this past week, and some analysts took this opportunity to reevaluate their stance on the stock.
Published:
Last Updated:
Target, Valeant, DryShips, and SeaDrill posted new 52-week lows on Friday.
Published:
Last Updated:
Valeant Pharmaceuticals reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Valeant Pharmaceuticals, Salesforce.com and some of the other major companies reporting their quarterly results this week.
Published:
Last Updated:
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. However things look like they could be different in 2017.
Published:
Last Updated:
A few biopharma companies have made massive runs on Tuesday morning.
Published:
Last Updated:
Valeant Pharmaceuticals received a key FDA approval early on Thursday, but it seems to be a mixed blessing.
Published:
Last Updated:
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight move. Although...
Published:
Last Updated:
Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year, the health care sector was in trouble under fire from congressional...
Published:
Last Updated:
Valeant Pharmaceuticals made waves early on Tuesday after the company offered announcements of a late-stage psoriasis trial and the sale of a couple business segments.
Published:
Last Updated:
Several high-profile CEOs lost their jobs in 2016, along with one or two who "resigned" with the cooperation of their boards.
Published:
Last Updated:
While the selling was robust, it certainly wasn’t extraordinary, and it should be expected given the big run in the markets this year.
Published:
Last Updated:
December 15, 2016: Here are four stocks trading with relatively heavy volume among 65 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by about 8 to...
Published:
Last Updated: